Bessy Benejam

Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

Juan Fortea, Eduard Vilaplana, María Carmona‐Iragui et al. · The Lancet · 2020 · 315 citations · Full text

Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial

Rafael de la Torre, Susana Solá, Gimena Hernández et al. · The Lancet Neurology · 2016 · 274 citations · Full text

Down Syndrome, Intellectual Impairment, Young Adults +7

Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in <scp>D</scp>own syndrome mouse models and in humans

Rafael de la Torre, Susana Solá, Meritxell Pons‐Espinal et al. · Molecular Nutrition & Food Research · 2013 · 270 citations

Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

Juan Fortea, María Carmona‐Iragui, Bessy Benejam et al. · The Lancet Neurology · 2018 · 205 citations

Down Syndrome, Alzheimer's Disease, Csf Biomarkers +11

The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders

Daniel Alcolea, Jordi Clarimón, María Carmona‐Iragui et al. · Alzheimer s & Dementia Translational Research & Clinical Interventions · 2019 · 121 citations · Full text